Archives

According to IQVIA Institute’s Omnitrope® case

According to IQVIA Institute’s Omnitrope® case study, usage has risen by 140% in the United Kingdom since the launc… https://t.co/E41VVqlG70

Biosimilar Uptake on the Rise in Europe https://t.

Biosimilar Uptake on the Rise in Europe

https://t.co/5XiJ5bTEAs

#HEOR #Biosimilars #Therapeutics #Biotech #Pharma https://t.co/OzN7n4YlzC

The Big Three PBMs’ 2023 Formulary Exclusions: O

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars @DrugChannels… https://t.co/BjYzXDIaEm

@HaruunYEG Are you supporting governments determin

@HaruunYEG Are you supporting governments determining “best” options for drug use as they have switching patients f… https://t.co/8nRivSMJNA

From our FAQ and #IBD myths section: https://t.co/

From our FAQ and #IBD myths section: https://t.co/xzkyKPpvj3

✨ You CAN be very sick without looking like you are ✨… https://t.co/hLETIz40s7

HEALTHY BODY: “Managing Crohn’s Disease: A Per

HEALTHY BODY: “Managing Crohn’s Disease: A Personal Journey” – “Living w/ Crohn’s disease isn’t easy…it can be ma… https://t.co/c7aAgLS3U9